CMV recombinant antigen p150
| CAT. # | RP-05 |
| Product description | The recombinant protein contains the CMV P150 (UL32) immunodominant regions, expressed and derived from E.coli in soluble form |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris, 5mM Glutathione, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
CMV recombinant antigen p28
| CAT. # | RP-09 |
| Product description | The recombinant protein contains CMV p28 (UL99) immunodominant regions, expressed and derived from E.coli in soluble form |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris, 20mM Glutathione, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
CMV recombinant antigen p52
| CAT. # | RP-10 |
| Product description | The recombinant protein contains CMV p28 (UL99) immunodominant regions, expressed and derived from E.coli |
| Purification methods | Extraction of recombinant protein from washed Inclusion Bodies |
| Buffer composition | 50mM Tris, 8M Urea, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
CMV recombinant antigen p65
| CAT. # | RP-11 |
| Product description | The recombinant protein contains CMV p65 immunodominant regions, expressed and derived from E.coli |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |